Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02741570 · COMPLETED
Trial details
- NCT number
- NCT02741570
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-05
- Primary completion
- 2021-05-10
- Enrollment
- 947
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.